NDC product
Drax Exametazime
NDC 65174-200 · Jubilant DraxImage Inc., dba Jubilant Radiopharma
Key facts
| Product NDC | 65174-200 |
|---|---|
| Proprietary name | Drax Exametazime |
| Nonproprietary name | Kit for the Preparation of Technetium Tc 99m Exametazime for Leukocyte Labeling |
| Substances | TECHNETIUM TC-99M EXAMETAZIME |
| Dosage form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Labeler | Jubilant DraxImage Inc., dba Jubilant Radiopharma |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA208870 |
| Pharmacologic classes | Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA] |
| Marketing start | Aug 17, 2017 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: